16 | | - | providing a short title; creating s. 456.0302, F.S.; 3 |
---|
17 | | - | providing definitions; providing requirements for 4 |
---|
18 | | - | persons administering intravenous vitamin treatment; 5 |
---|
19 | | - | requiring the Board of Nursing, the Board of Medicine, 6 |
---|
20 | | - | and the Board of Osteopathic Medicine to adopt rules 7 |
---|
21 | | - | establishing procedures to administer intravenous 8 |
---|
22 | | - | vitamin treatment and emergency protocols; pr oviding 9 |
---|
23 | | - | penalties; providing an effective date. 10 |
---|
| 16 | + | providing a short title; creating s. 464.0124, F.S.; 3 |
---|
| 17 | + | providing a definition; requiring the Board of Nursing 4 |
---|
| 18 | + | to adopt rules establishing procedures to administer 5 |
---|
| 19 | + | certain intravenous treatment and emergency protocols; 6 |
---|
| 20 | + | providing requirements for persons administering such 7 |
---|
| 21 | + | treatment; providing an effective date. 8 |
---|
| 22 | + | 9 |
---|
| 23 | + | Be It Enacted by the Legislature of the State of Flo rida: 10 |
---|
25 | | - | Be It Enacted by the Legislature of the State of Florida: 12 |
---|
26 | | - | 13 |
---|
27 | | - | Section 1. This act may be cited as the "Stephanie Balais 14 |
---|
28 | | - | Act." 15 |
---|
29 | | - | Section 2. Section 456.0302, Florida Statutes, is created 16 |
---|
30 | | - | to read: 17 |
---|
31 | | - | 456.0302 Administering intravenous vitamin treatment. — 18 |
---|
32 | | - | (1) As used in this section, the term: 19 |
---|
33 | | - | (a) "Health care provider" means a person licensed under 20 |
---|
34 | | - | chapter 458, chapter 459, or chapter 464. 21 |
---|
35 | | - | (b) "Intravenous vitamin treatment" means a procedure in 22 |
---|
36 | | - | which high concentrations of vitamins and minerals are 23 |
---|
37 | | - | administered directly into a person's bloodstream, allowing 24 |
---|
38 | | - | rapid absorption of higher doses of the vitamins and minerals 25 |
---|
| 25 | + | Section 1. This act may be cited as the "Stephanie Balais 12 |
---|
| 26 | + | Act." 13 |
---|
| 27 | + | Section 2. Section 464.0124, Florida Statutes, is created 14 |
---|
| 28 | + | to read: 15 |
---|
| 29 | + | 464.0124 Administering intravenous vitamin treatment. — 16 |
---|
| 30 | + | (1) "Intravenous vitamin treatment" means a procedu re in 17 |
---|
| 31 | + | which high concentrations of vitamins and minerals are 18 |
---|
| 32 | + | administered directly into the person's bloodstream, allowing 19 |
---|
| 33 | + | rapid absorption of higher doses of the vitamins and minerals 20 |
---|
| 34 | + | than if received through food or supplements. 21 |
---|
| 35 | + | (2) The board shall ado pt rules establishing procedures to 22 |
---|
| 36 | + | safely administer intravenous vitamin treatment and establish 23 |
---|
| 37 | + | protocols to follow in the event of an emergency that would 24 |
---|
| 38 | + | place the life or health of a recipient of such treatment in 25 |
---|
51 | | - | than if received through food or supplements. 26 |
---|
52 | | - | (2) A health care provider adminis tering intravenous 27 |
---|
53 | | - | vitamin treatment shall: 28 |
---|
54 | | - | (a) Obtain a complete self -screening risk assessment 29 |
---|
55 | | - | questionnaire from a patient before administering intravenous 30 |
---|
56 | | - | vitamin treatment. The health care provider must use a form 31 |
---|
57 | | - | adopted by rule by the applicable b oard. 32 |
---|
58 | | - | (b) Provide a patient with information related to 33 |
---|
59 | | - | potential side effects and risks of intravenous vitamin 34 |
---|
60 | | - | treatment and instructions on when to seek medical attention. 35 |
---|
61 | | - | (c) Provide a patient with a visit summary. 36 |
---|
62 | | - | (d) Notify a patient's designat ed physician that an 37 |
---|
63 | | - | intravenous vitamin treatment was administered. 38 |
---|
64 | | - | (e) Have a written plan for the provision of emergency 39 |
---|
65 | | - | care. A copy of the emergency plan must be kept at the location 40 |
---|
66 | | - | offering intravenous vitamin treatment. The plan must include 41 |
---|
67 | | - | the following: 42 |
---|
68 | | - | 1. The name and address of the hospital closest to the 43 |
---|
69 | | - | location at which the intravenous vitamin treatment is being 44 |
---|
70 | | - | performed. 45 |
---|
71 | | - | 2. Reasons for which an emergency transfer of a patient 46 |
---|
72 | | - | may be required. 47 |
---|
73 | | - | 3. Medical services to be used in the e vent of a health 48 |
---|
| 51 | + | danger. The rules shall include requi rements for all of the 26 |
---|
| 52 | + | following: 27 |
---|
| 53 | + | (a) Education and training requirements to administer 28 |
---|
| 54 | + | intravenous vitamin treatment. 29 |
---|
| 55 | + | (b) Self-screening risk assessments. 30 |
---|
| 56 | + | (c) Information that a person administering intravenous 31 |
---|
| 57 | + | vitamin treatment must provide to a cl ient before administering 32 |
---|
| 58 | + | such treatment. 33 |
---|
| 59 | + | (d) Documentation regarding the process of administering 34 |
---|
| 60 | + | intravenous vitamin treatment. 35 |
---|
| 61 | + | (e) Notification that must be provided to a client's 36 |
---|
| 62 | + | designated physician that an intravenous vitamin treatment was 37 |
---|
| 63 | + | administered. 38 |
---|
| 64 | + | (f) Evaluation and review of the administration practices 39 |
---|
| 65 | + | used to administer intravenous vitamin treatment. 40 |
---|
| 66 | + | (3) For a new client requesting intravenous vitamin 41 |
---|
| 67 | + | treatment, and at least every 6 months for each returning 42 |
---|
| 68 | + | client, a person administe ring intravenous vitamin treatment 43 |
---|
| 69 | + | must do all of the following: 44 |
---|
| 70 | + | (a) Obtain a complete self -screening risk assessment. 45 |
---|
| 71 | + | (b) Perform a client assessment. 46 |
---|
| 72 | + | (c) Provide the client with a visit summary. 47 |
---|
| 73 | + | (d) Advise the client to seek medical help in case of an 48 |
---|
88 | | - | vitamin treatment to a patient if the provider determines that 51 |
---|
89 | | - | it is unsafe to administer such treatment based upon the results 52 |
---|
90 | | - | of the self-screening risk assessment qu estionnaire or 53 |
---|
91 | | - | otherwise. 54 |
---|
92 | | - | (4) The respective boards shall adopt rules establishing 55 |
---|
93 | | - | procedures to safely administer intravenous vitamin treatment 56 |
---|
94 | | - | and establish protocols to follow in the event of a health 57 |
---|
95 | | - | emergency, including, but not limited to, requirem ents for: 58 |
---|
96 | | - | (a) Education and training requirements for health care 59 |
---|
97 | | - | providers authorized to administer intravenous vitamin 60 |
---|
98 | | - | treatment. 61 |
---|
99 | | - | (b) Self-screening risk assessments. 62 |
---|
100 | | - | (c) Information that a health care provider must provide 63 |
---|
101 | | - | to a patient before admi nistering intravenous vitamin treatment. 64 |
---|
102 | | - | (d) Documentation regarding the process of administering 65 |
---|
103 | | - | intravenous vitamin treatment. 66 |
---|
104 | | - | (e) Notification that must be provided to a patient's 67 |
---|
105 | | - | designated physician if intravenous vitamin treatment is 68 |
---|
106 | | - | administered. 69 |
---|
107 | | - | (f) Evaluation and review of the administration practices 70 |
---|
108 | | - | used to administer intravenous vitamin treatment. 71 |
---|
109 | | - | (5) Violation of this section constitutes grounds for 72 |
---|
110 | | - | disciplinary action under this chapter and chapter 458, chapter 73 |
---|
111 | | - | 459, or chapter 464, as applicable. 74 |
---|
112 | | - | Section 3. This act shall take effect July 1, 2023. 75 |
---|
| 88 | + | shall: 51 |
---|
| 89 | + | (a) Obtain a complete self -screening risk assessment 52 |
---|
| 90 | + | questionnaire that has been approved by the board from the 53 |
---|
| 91 | + | client before administering intravenous vitamin treatment. If 54 |
---|
| 92 | + | the results of the assessment indicate that it is unsafe to 55 |
---|
| 93 | + | administer to the client, the procedure may not be performed. 56 |
---|
| 94 | + | (b) Provide the client with the following information: 57 |
---|
| 95 | + | 1. Any potential side effects and risks of intravenous 58 |
---|
| 96 | + | vitamin treatment. 59 |
---|
| 97 | + | 2. Instructions on when to seek medical attention. 60 |
---|
| 98 | + | (c) Have a written plan for the appropriate provision of 61 |
---|
| 99 | + | emergency care. A copy of the emergency plan must be kept at the 62 |
---|
| 100 | + | location offering intravenous vitamin treatment. The plan must 63 |
---|
| 101 | + | include the following: 64 |
---|
| 102 | + | 1. The name and address of hospital closest to the 65 |
---|
| 103 | + | location at which the intravenous vitamin treatment is being 66 |
---|
| 104 | + | performed. 67 |
---|
| 105 | + | 2. Reasons for which an emergency transfer of a client may 68 |
---|
| 106 | + | be required. 69 |
---|
| 107 | + | 3. Medical services to be used in the event o f an 70 |
---|
| 108 | + | emergency that would place the life or health of a client in 71 |
---|
| 109 | + | serious jeopardy. 72 |
---|
| 110 | + | Section 3. This act shall take effect July 1, 2023. 73 |
---|